|
|
|
40
|
00521
|
XELODA 500MG TAB (ROC/AHI) CAPECITABINE
|
CAPECITABINE
|
XELODA
|
120'S
|
C
|
326.20
|
2.72
|
TABLET
|
0
|
TAB
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0451Z
|
BACTRIM FORTE 800MG|160MG TAB (ROC) SULFAMETHOXAZOLE|TRIMETH (B)
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
BACTRIM FORTE
|
10'S
|
B
|
11.42
|
1.1417
|
TAB
|
28
|
BOX
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081220
|
SULPHONAMIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SULPHONAMIDES
|
|
|
|
|
41
|
04536
|
BACTRIM 80MG|16MG/ML INJ (ROC) SULFAMETHOXAZOLE|TRIMETHOPRIM (C)
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
BACTRIM
|
10X5ML
|
C
|
10.6
|
1.0602
|
AMP
|
0
|
BOX
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081220
|
SULPHONAMIDES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SULPHONAMIDES
|
|
|
|
|
41
|
1232B
|
ISOSORBIDE DINITRATE 5MG TAB (ROL)
|
ISOSORBIDE DINITRATE
|
ISOSORBIDE DINITRATE
|
100'S
|
A
|
116.72
|
1.1672
|
TAB
|
120
|
BOX
|
ROL
|
ROXANE LABORATORIES INC.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
241208
|
NITRATES AND NITRITES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NITRATES AND NITRITES
|
|
|
|
|
41
|
1351F
|
RESTRIVA 500MG TAB (TRO) METAMIZOL
|
METAMIZOL
|
RESTRIVA
|
150'S
|
A
|
21.77
|
0.1451
|
TAB
|
30
|
BOX
|
TRO
|
TROIKAA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2808
|
ANALGESICS-ANTIPYRETICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANALGESICS-ANTIPYRETICS
|
2024-03-11
|
|
|
|
40
|
1763L
|
PROMETHAZINE 25MG/ML INJ (ROL/AHI)
|
PROMETHAZINE
|
PROMETHAZINE
|
25X1ML
|
B
|
204.04
|
8.16
|
INJECTION
|
0
|
AMP
|
ROL
|
ROXANE LABORATORIES INC.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|
|
|
|
40
|
36223
|
PROLOPA 50MG | 200MG TAB (ROC/AHI) BENSERAZIDE |
|
BENSERAZIDE|LEVODOPA
|
PROLOPA
|
30'S
|
A
|
40.77
|
1.36
|
TABLET
|
240
|
TAB
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283616
|
DOPAMINE PRECURSORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
36223
|
PROLOPA 50MG|200MG TAB (ROC) BENSERAZIDE|LEVODOPA
|
BENSERAZIDE|LEVODOPA
|
PROLOPA
|
30'S
|
A
|
30.15
|
1.005
|
TAB
|
240
|
BOX
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283616
|
DOPAMINE PRECURSORS
|
2024-09-27
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE PRECURSORS
|
2024-09-27
|
|
|
|
40
|
41811
|
MABTHERA 10MG/ML INJ (ROC/AHI) RITUXIMAB
|
RITUXIMAB
|
MABTHERA
|
100MG VIAL
|
C
|
1,391.78
|
1,391.78
|
INJECTION
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
41811
|
MABTHERA 10MG/ML INJ (ROC) RITUXIMAB (BQ)
|
RITUXIMAB
|
MABTHERA
|
100MG VIAL
|
BQ
|
1391.78
|
1391.7819
|
VIAL
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4181A
|
AVASTIN 25MG/ML INJ (ROC/AHI) BEVACIZUMAB
|
BEVACIZUMAB
|
AVASTIN
|
100MG VIAL
|
C
|
1,003.06
|
1,003.06
|
INJECTION
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4181A
|
AVASTIN 25MG/ML INJ (ROC) BEVACIZUMAB (C)
|
BEVACIZUMAB
|
AVASTIN
|
100MG VIAL
|
C
|
1003.06
|
1003.0616
|
VIAL
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4181B
|
AVASTIN 25MG/ML INJ (ROC/AHI) BEVACIZUMAB
|
BEVACIZUMAB
|
AVASTIN
|
400MG VIAL
|
C
|
4,012.25
|
4,012.25
|
INJECTION
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4181B
|
AVASTIN 25MG/ML INJ (ROC) BEVACIZUMAB (C)
|
BEVACIZUMAB
|
AVASTIN
|
400MG VIAL
|
C
|
4012.25
|
4012.2462
|
VIAL
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4181BB
|
MABTHERA 10MG/ML INJ (ROC/AHI) RITUXIMAB
|
RITUXIMAB
|
MABTHERA
|
50ML
|
C
|
3,479.45
|
3,479.45
|
INJECTION
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4181BB
|
MABTHERA 10MG/ML INJ (ROC) RITUXIMA (BQ)
|
RITUXIMAB
|
MABTHERA
|
50ML
|
BQ
|
3479.45
|
3479.4547
|
VIAL
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4181BC
|
MABTHERA SC 1400MG INJ (ROC/AHI) RITUXIMAB
|
RITUXIMAB
|
MABTHERA SC
|
11.7ML
|
C
|
4,392.81
|
4,392.81
|
INJECTION
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4181BC
|
MABTHERA SC 1400MG INJ (ROC) RITUXIMAB (BQ)
|
RITUXIMAB
|
MABTHERA SC
|
11.7ML
|
BQ
|
4392.81
|
4392.8116
|
VIAL
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4181BL
|
PHESGO 60MG/ML|60MG/ML INJ (ROC) PERTUZUMAB|TRASTUZUMAB (C)
|
PERTUZUMAB|TRASTUZUMAB
|
PHESGO
|
10ML
|
C
|
12626.62
|
12626.62
|
VIAL
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
SC
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
41
|
4181BW
|
PHESGO 1200MG|600MG INJ (ROC) PERTUZUMAB|TRASTUZUMAB (C)
|
PERTUZUMAB|TRASTUZUMAB
|
PHESGO
|
15ML VIAL
|
C
|
21270.89
|
21270.885
|
VIAL
|
0
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
SC
|
0
|
ANTINEOPLASTICS
|
|
